Four-Drug attack plus precision radiation targets tough lung cancer
NCT ID NCT06775743
Summary
This study is testing a new combination treatment for people with advanced lung cancer that has a specific genetic change (EGFR mutation) and has stopped responding to their first treatment. It combines four drugs (an immunotherapy, a blood vessel blocker, and two chemotherapies) with a very precise, high-dose form of radiation. The goal is to see if this approach is safe and can better control the cancer's growth and extend life for patients who have run out of standard options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University Shanghai Cancer Center
RECRUITINGShanghai, Shanghai Municipality, 200032, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.